The latest closing stock price for PMV Pharmaceuticals as of April 11, 2025 is 0.87.
An investor who bought $1,000 worth of PMV Pharmaceuticals stock at the IPO in 2020 would have $-977 today, roughly -1 times their original investment - a -52.87% compound annual growth rate over 5 years.
The all-time high PMV Pharmaceuticals stock closing price was 61.51 on December 31, 2020.
The PMV Pharmaceuticals 52-week high stock price is 2.26, which is 159.8% above the current share price.
The PMV Pharmaceuticals 52-week low stock price is 0.82, which is 5.7% below the current share price.
The average PMV Pharmaceuticals stock price for the last 52 weeks is 1.55.
An investor who bought $1,000 worth of PMV Pharmaceuticals stock at the IPO in 2020 would have $-977 today, roughly -1 times their original investment - a -52.87% compound annual growth rate over 5 years.
The all-time high PMV Pharmaceuticals stock closing price was 61.51 on December 31, 2020.
The PMV Pharmaceuticals 52-week high stock price is 2.26, which is 159.8% above the current share price.
The PMV Pharmaceuticals 52-week low stock price is 0.82, which is 5.7% below the current share price.
The average PMV Pharmaceuticals stock price for the last 52 weeks is 1.55.